Cargando…
The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743015/ https://www.ncbi.nlm.nih.gov/pubmed/31328862 http://dx.doi.org/10.1111/cts.12666 |
| _version_ | 1783451203375464448 |
|---|---|
| author | Marks, Peter |
| author_facet | Marks, Peter |
| author_sort | Marks, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6743015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67430152019-09-14 The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies Marks, Peter Clin Transl Sci Perspective John Wiley and Sons Inc. 2019-07-22 2019-09 /pmc/articles/PMC6743015/ /pubmed/31328862 http://dx.doi.org/10.1111/cts.12666 Text en Published 2019. This article is a U.S. Government work and is in the public domain in the USA. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspective Marks, Peter The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title | The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title_full | The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title_fullStr | The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title_full_unstemmed | The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title_short | The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies |
| title_sort | fda’s regulatory framework for chimeric antigen receptor‐t cell therapies |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743015/ https://www.ncbi.nlm.nih.gov/pubmed/31328862 http://dx.doi.org/10.1111/cts.12666 |
| work_keys_str_mv | AT markspeter thefdasregulatoryframeworkforchimericantigenreceptortcelltherapies AT markspeter fdasregulatoryframeworkforchimericantigenreceptortcelltherapies |